Skip to main content
. 2020 Nov 6;27(9):1371–1378. doi: 10.1093/ibd/izaa283

TABLE 1.

Inflammatory Bowel Disease Baseline Medications

Crohn’s Disease N = 15
Steroids % (n)
 Prednisone 26.7% (4)
 Budesonide 6.7% (1)
Biologics
 Vedolizumab 20% (3)
 Certolizumab 13.3% (2)
 Adalimumab 6.7% (1)
 Infliximab 6.7% (1)
 Ustekinumab 6.7% (1)
 Cyclosporine 6.7% (1)
Mesalamine
 Oral 5-ASA 13.3% (2)
 Rectal 5-ASA 6.7% (1)
Immunomodulators
 Azathioprine 13.3% (2)
 Methotrexate 13.3% (2)
Ulcerative Colitis N = 35
Steroids
 Prednisone 48.6% (17)
 Budesonide 5.7% (2)
 Rectal Corticosteroids 8.6% (3)
Biologics
 Adalimumab 8.6% (3)
 Vedolizumab 22.9% (8)
 Infliximab 17.1% (6)
 Tofacitanib 2.9% (1)
 Cyclosporine 2.9% (1)
Mesalamine
 Rectal 5-ASA 11.4% (4)
 Oral 5-ASA 57% (20)
Immunomodulator
 Methotrexate 2.9% (1)